COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 9 | -47.1% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 17 | -95.7% | 0.00% | -100.0% |
Q3 2020 | $8,000 | -83.0% | 396 | -85.5% | 0.00% | -66.7% |
Q2 2020 | $47,000 | -13.0% | 2,727 | -18.9% | 0.00% | -25.0% |
Q1 2020 | $54,000 | -36.5% | 3,362 | -18.1% | 0.00% | -20.0% |
Q4 2019 | $85,000 | -12.4% | 4,106 | -51.7% | 0.01% | -16.7% |
Q3 2019 | $97,000 | +1112.5% | 8,495 | +1299.5% | 0.01% | +500.0% |
Q2 2019 | $8,000 | -76.5% | 607 | -73.8% | 0.00% | -66.7% |
Q1 2019 | $34,000 | -45.2% | 2,318 | -36.9% | 0.00% | -50.0% |
Q4 2018 | $62,000 | +785.7% | 3,672 | +644.8% | 0.01% | +500.0% |
Q3 2018 | $7,000 | -100.0% | 493 | -85.4% | 0.00% | -85.7% |
Q2 2018 | $80,637,000 | +8063600.0% | 3,381 | +6401.9% | 0.01% | – |
Q1 2018 | $1,000 | 0.0% | 52 | +4.0% | 0.00% | – |
Q4 2017 | $1,000 | -90.0% | 50 | -94.5% | 0.00% | -100.0% |
Q1 2017 | $10,000 | +42.9% | 902 | +101.3% | 0.00% | 0.0% |
Q4 2016 | $7,000 | – | 448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |